Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$124.6M
4 rounds on record
Latest round
$40M
Venture round · Aug 2024 · 2 yr ago
Team
14
US Form 5500 (plan participants) · Dec 2025
Grants
$2.3M
2 grants · CORDIS
Backers
1
Longitude Capital
The money's age
Long since its last round
26 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 14, 2024 Raised a round Venture round $40M · SEC Form D Sep 8, 2023 Won a grant $2M · CORDIS Sep 22, 2022 Won a grant $300k · CORDIS 2020 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Aug 2024 $40M — SEC Form D
Venture round Oct 2023 $84.6M — SEC Form D
Grant Sep 2023 $2M — CORDIS
Grant Sep 2022 $300k — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity OrsoBio, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Gangadhara GanapatiExecutive Officer, DirectorSEC Form D
Mani SubramanianExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

Overview

Advancing first-in-class therapies torestore energy homeostasis. OrsoBio is developing novel approaches to treat patients with severe metabolic disorders, including obesity, diabetes, severe dyslipidemias, MASH, and more.

People

Gangadhara Ganapati
Executive Officer, Director
Mani Subramanian
Executive Officer, Director
Cory Freedland
Director
Muzammil Mansuri
Director
Matthew Young
Director
Edward Fleming
Director
Srinivas Akkaraju
Director
Evan Rachlin
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Palo Alto United States
HQ

Financials

Total raised
$126.9M
Latest round
Venture - Series Unknown
Funding rounds
4
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $40M Details
Venture - Series Unknown 2023 $84.6M Details
Grant 2023 $2M Details
Grant 2022 $300k Details